Mayo Clinic in Florida
Jacksonville, Florida, 32224-9980, United States
Location status: Recruiting
Location contact
Clinical Trials Referral Office
CONTACT
Dev Mukhopadhyay, PhD
PRINCIPAL_INVESTIGATOR
Megan Warner
CONTACT
NCT Number: NCT07000864
The purpose of this study is to obtain unused resected tumor tissue sample and associated clinical data from patients enrolled in this study to research ex vivo treatment response and integrity of tumor microenvironment using omics analysis and imaging while maintaining cell stability in a live environment.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Jacksonville, Florida, 32224-9980, United States
Location status: Recruiting
Clinical Trials Referral Office
CONTACT
Dev Mukhopadhyay, PhD
PRINCIPAL_INVESTIGATOR
Megan Warner
CONTACT
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Lab-based correlative study; no intervention
Time frame: Up to 72 hours
Tumor sample fragments will be treated with various combination of chemotherapy and immunotherapy drugs that are commonly used to treat patients clinically (panel of drugs will be selected based on cancer type). response to the treatment will be assessed at multiple timepoints during a 72-hour period.
Contact information is provided by the study sponsor or research team.
Clinical Trials Referral Office
CONTACT
Megan Warner
CONTACT
Mayo Clinic
Other
Predicting Response to Therapy From Analysis of Live Tumor Fragments of Surgical Resections
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05997017
Cancer, Disease Attributes
Little Rock, Arkansas, United States
View Trial DetailsNCT07147465
Cancer, Disease Attributes
Lyon, France
View Trial DetailsNCT06819215
Adnexal Diseases, Biliary Cancer
Jinan, Shandong, China
View Trial DetailsNCT00027326
Cancer, Carcinoma
Bethesda, Maryland, United States
View Trial Details